Kowalski Filip, Kuffel Błażej, Późniak Michał, Lipowski Pavel, Czarnogorski Michal, Wilamowski Jacek, Ostrowski Adam, Adamowicz Jan, Drewa Tomasz
Antoni Jurasz Memorial University Hospital No.1, Bydgoszcz, Poland.
L.Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland.
World J Urol. 2025 Apr 1;43(1):201. doi: 10.1007/s00345-025-05574-9.
The current results of endoscopic treatment of ureteral strictures are characterized by very divergent treatment results, which is due to a wide range of criteria for including patients in the analyses and different definitions of effective treatment. In this retrospect study we wanted to introduce a possibility of curing ureteral strictures depending on their type and degree with the use of self-expanding ureteral stents (SUS).
33 patients with ureteral strictures received endourological treatment with the use of Allium® SUS (2 patients with SUS placed on both sides). Patients were divided into 2 groups: patients with uncomplicated strictures (Grp 1) and patients with complicated strictures (Grp 2). Uncomplicated stricture was defined as a single stricture below 2 cm. A complicated stricture was defined as a stricture over 2 cm and/or multiple strictures. The follow-up time was 24 months. All patients were scheduled for renoscintigraphy during the treatment. A full therapeutic success was defined as no tight stenosis in renoscintigraphic furosemide test after SUS explantation.
In Grp 1, full therapeutic success was achieved in 80% of patients, which was statistically significant (p < 0.001). Serious complications (Clavien-Dindo > 3a) occurred significantly more often in Grp 2 (p = 0.046). Renal outflow during stenting was present in 70% of the patients in Grp 2.
A full therapeutic success of endoscopic, SUS-assisted treatment can be considered among patients with short, single ureteral stricture. In long and/or multiple strictures, SUS can be used as drainage element, but full recovery of the stricture is unlikely.
目前输尿管狭窄的内镜治疗结果差异很大,这是由于纳入分析的患者标准范围广泛以及有效治疗的定义不同。在这项回顾性研究中,我们想介绍一种根据输尿管狭窄的类型和程度使用自膨式输尿管支架(SUS)进行治疗的可能性。
33例输尿管狭窄患者接受了使用Allium® SUS的腔内泌尿外科治疗(2例患者双侧放置了SUS)。患者分为2组:单纯性狭窄患者(第1组)和复杂性狭窄患者(第2组)。单纯性狭窄定义为长度小于2 cm的单一狭窄。复杂性狭窄定义为长度超过2 cm的狭窄和/或多处狭窄。随访时间为24个月。所有患者在治疗期间均安排进行肾闪烁扫描。完全治疗成功定义为SUS取出后肾闪烁扫描呋塞米试验中无严重狭窄。
在第1组中,80%的患者取得了完全治疗成功,具有统计学意义(p < 0.001)。第2组严重并发症(Clavien-Dindo > 3a)的发生率明显更高(p = 0.046)。第2组70%的患者在置入支架期间存在肾流出。
对于短的、单一输尿管狭窄患者,可考虑内镜下SUS辅助治疗取得完全治疗成功。对于长的和/或多处狭窄,SUS可作为引流元件使用,但狭窄不太可能完全恢复。